$NERV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Minerva Neurosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Minerva Neurosciences, Inc.. Get notifications about new insider transactions in Minerva Neurosciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 4.34 | 7,500 | 32,550 | 7,500 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | D | 4.34 | 7,500 | 32,550 | 0 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 6.00 | 127,513 | 765,078 | 127,513 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | D | 6.00 | 127,513 | 765,078 | 0 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 9.49 | 80,356 | 762,578 | 80,356 | |
Feb 02 2018 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | D | 9.49 | 80,356 | 762,578 | 0 | |
Jan 04 2018 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 6.20 | 200,000 | 1,240,000 | 200,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 56,250 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Option Exercise | A | 6.10 | 350,000 | 2,135,000 | 350,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Sell | S | 5.85 | 2,194 | 12,835 | 16,556 | 18.8 K to 16.6 K (-11.70 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | CEO | Buy | M | 0.00 | 18,750 | 0 | 18,750 | 0 to 18.8 K |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 0.00 | 8,750 | 0 | 26,250 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 6.10 | 120,000 | 732,000 | 120,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 5.80 | 2,906 | 16,855 | 14,177 | 17.1 K to 14.2 K (-17.01 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 0.00 | 8,750 | 0 | 17,083 | 8.3 K to 17.1 K (+105.00 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 6.10 | 120,000 | 732,000 | 120,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 5.80 | 1,661 | 9,634 | 8,339 | 10 K to 8.3 K (-16.61 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 6.10 | 125,000 | 762,500 | 125,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 6.10 | 175,000 | 1,067,500 | 175,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Option Exercise | A | 6.10 | 200,000 | 1,220,000 | 200,000 | |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 5.79 | 5,829 | 33,750 | 191,869 | 197.7 K to 191.9 K (-2.95 %) |
Dec 15 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Buy | M | 0.00 | 12,500 | 0 | 197,698 | 185.2 K to 197.7 K (+6.75 %) |
Dec 12 2017 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Option Exercise | A | 6.05 | 775,000 | 4,688,750 | 775,000 | |
Dec 12 2017 | NERV | Minerva Neuroscien ... | Russell Richard E. | President | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Dec 12 2017 | NERV | Minerva Neuroscien ... | HASLER HANS PETER | Director | Option Exercise | A | 5.70 | 40,000 | 228,000 | 40,000 | |
Dec 12 2017 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 5.70 | 40,000 | 228,000 | 40,000 | |
Sep 14 2017 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Sell | J | 0.00 | 3,892,256 | 389 | 0 | 3.9 M to 0 (-100.00 %) |
Sep 05 2017 | NERV | Minerva Neuroscien ... | Saoud Jay | SVP and Head of R&D | Option Exercise | A | 6.45 | 100,000 | 645,000 | 100,000 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | D | 10.20 | 12,500 | 127,500 | 0 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 4.71 | 25,000 | 117,750 | 25,000 | |
Jul 26 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | D | 4.71 | 25,000 | 117,750 | 0 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 4.71 | 7,250 | 34,148 | 49,750 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 5.19 | 14,381 | 74,637 | 43,143 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 11.00 | 10,381 | 114,191 | 5,000 | 15.4 K to 5 K (-67.49 %) |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 10.00 | 11,250 | 112,500 | 15,381 | 26.6 K to 15.4 K (-42.24 %) |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 4.71 | 7,250 | 34,148 | 26,631 | 19.4 K to 26.6 K (+37.41 %) |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 5.19 | 14,381 | 74,637 | 19,381 | 5 K to 19.4 K (+287.62 %) |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 10.00 | 12,500 | 125,000 | 12,500 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 5.19 | 17,500 | 90,825 | 39,774 | |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Sell | S | 11.00 | 17,500 | 192,500 | 0 | 17.5 K to 0 (-100.00 %) |
Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 5.19 | 17,500 | 90,825 | 17,500 | 0 to 17.5 K |
Mar 21 2017 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Buy | P | 7.89 | 25,000 | 197,250 | 50,000 | 25 K to 50 K (+100.00 %) |
Mar 21 2017 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Buy | P | 8.34 | 25,000 | 208,500 | 25,000 | 0 to 25 K |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 11.00 | 1,692 | 18,612 | 185,198 | 186.9 K to 185.2 K (-0.91 %) |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & CBO | Sell | S | 11.02 | 19,758 | 217,733 | 186,890 | 206.6 K to 186.9 K (-9.56 %) |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Option Exercise | M | 4.71 | 2,185 | 10,291 | 285,719 | |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Option Exercise | M | 4.71 | 32,096 | 151,172 | 287,904 | |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Sell | S | 11.00 | 2,185 | 24,035 | 0 | 2.2 K to 0 (-100.00 %) |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Buy | M | 4.71 | 2,185 | 10,291 | 2,185 | 0 to 2.2 K |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Sell | S | 11.02 | 32,096 | 353,698 | 0 | 32.1 K to 0 (-100.00 %) |
Feb 07 2017 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Buy | M | 4.71 | 32,096 | 151,172 | 32,096 | 0 to 32.1 K |
Jan 13 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | M | 4.71 | 1,600 | 7,536 | 67,400 | |
Jan 13 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Sell | S | 12.03 | 1,600 | 19,248 | 8,333 | 9.9 K to 8.3 K (-16.11 %) |
Jan 13 2017 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Buy | M | 4.71 | 1,600 | 7,536 | 9,933 | 8.3 K to 9.9 K (+19.20 %) |
Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 5.19 | 250 | 1,298 | 57,274 | |
Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 4.71 | 17,250 | 81,248 | 51,750 | |
Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Sell | S | 12.00 | 17,500 | 210,000 | 0 | 17.5 K to 0 (-100.00 %) |
Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 5.19 | 250 | 1,298 | 17,500 | 17.3 K to 17.5 K (+1.45 %) |
Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 4.71 | 17,250 | 81,248 | 17,250 | 0 to 17.3 K |
Jan 05 2017 | NERV | Minerva Neuroscien ... | Davidson Michael | Chief Medical Offic ... | Option Exercise | A | 11.75 | 145,000 | 1,703,750 | 145,000 | |
Dec 29 2016 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | M | 4.71 | 12,000 | 56,520 | 57,000 | |
Dec 29 2016 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Sell | S | 12.51 | 17,000 | 212,670 | 5,000 | 22 K to 5 K (-77.27 %) |
Dec 29 2016 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Buy | M | 4.71 | 12,000 | 56,520 | 22,000 | 10 K to 22 K (+120.00 %) |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Option Exercise | A | 13.45 | 150,000 | 2,017,500 | 150,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & Chief Bu ... | Option Exercise | A | 13.45 | 100,000 | 1,345,000 | 100,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Race Geoff | EVP, CFO & Chief Bu ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 13.45 | 60,000 | 807,000 | 60,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 13.45 | 35,000 | 470,750 | 35,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 13.45 | 35,000 | 470,750 | 35,000 | |
Dec 16 2016 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Dec 14 2016 | NERV | Minerva Neuroscien ... | Ollier Michele | Director | Option Exercise | X | 5.77 | 202,634 | 1,169,603 | 0 | |
Dec 14 2016 | NERV | Minerva Neuroscien ... | Ollier Michele | Director | Buy | X | 5.77 | 202,634 | 1,169,603 | 4,690,906 | 4.5 M to 4.7 M (+4.51 %) |
Dec 14 2016 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Option Exercise | X | 5.77 | 202,634 | 1,169,603 | 0 | |
Dec 14 2016 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | X | 5.77 | 202,634 | 1,169,603 | 4,690,906 | 4.5 M to 4.7 M (+4.51 %) |
Dec 14 2016 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | X | 5.77 | 202,634 | 1,169,603 | 0 | |
Dec 14 2016 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Buy | X | 5.77 | 202,634 | 1,169,603 | 4,690,906 | 4.5 M to 4.7 M (+4.51 %) |
Aug 12 2016 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Sell | S | 10.00 | 1,000,000 | 10,000,000 | 4,488,272 | 5.5 M to 4.5 M (-18.22 %) |
Aug 12 2016 | NERV | Minerva Neuroscien ... | Ollier Michele | Director | Sell | S | 10.00 | 1,000,000 | 10,000,000 | 4,488,272 | 5.5 M to 4.5 M (-18.22 %) |
Aug 12 2016 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Sell | S | 10.00 | 1,000,000 | 10,000,000 | 4,488,272 | 5.5 M to 4.5 M (-18.22 %) |
Jun 21 2016 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Buy | P | 10.73 | 27,935 | 299,603 | 27,935 | 0 to 27.9 K |
Jun 21 2016 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Buy | P | 10.95 | 27,700 | 303,398 | 209,188 | 181.5 K to 209.2 K (+15.26 %) |
Jun 17 2016 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Jun 17 2016 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Jun 17 2016 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Jun 17 2016 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Jun 17 2016 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 10.20 | 12,500 | 127,500 | 12,500 | |
Mar 18 2016 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Buy | P | 5.51 | 181,488 | 999,999 | 181,488 | 0 to 181.5 K |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Luthringer Remy | President & CEO | Option Exercise | A | 4.71 | 320,000 | 1,507,200 | 320,000 | |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 4.71 | 69,000 | 324,990 | 69,000 | |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | SVP, Chief Accounti ... | Option Exercise | A | 4.71 | 69,000 | 324,990 | 69,000 | |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | SVP & Chief Operati ... | Option Exercise | A | 4.71 | 69,000 | 324,990 | 69,000 | |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Race Geoff | EVP & Chief Financi ... | Option Exercise | A | 4.71 | 175,000 | 824,250 | 175,000 | |
Dec 08 2015 | NERV | Minerva Neuroscien ... | Vandervelpen Nico | Director | Option Exercise | A | 4.71 | 25,000 | 117,750 | 25,000 | |
Nov 03 2015 | NERV | Minerva Neuroscien ... | Kupfer David | Director | Option Exercise | A | 5.41 | 25,000 | 135,250 | 25,000 | |
Jun 18 2015 | NERV | Minerva Neuroscien ... | Laghrissi-Thode Fouzia | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Apr 16 2015 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | VP, Chief Accountin ... | Option Exercise | A | 5.19 | 57,524 | 298,550 | 57,524 | |
Apr 16 2015 | NERV | Minerva Neuroscien ... | Reilly Joseph H. | VP & Chief Operatin ... | Option Exercise | A | 5.19 | 57,524 | 298,550 | 57,524 | |
Apr 16 2015 | NERV | Minerva Neuroscien ... | Race Geoff | EVP & Chief Financi ... | Option Exercise | A | 5.19 | 213,133 | 1,106,160 | 213,133 | |
Apr 16 2015 | NERV | Minerva Neuroscien ... | Levine Mark S. | VP,General Counsel ... | Option Exercise | A | 5.19 | 57,524 | 298,550 | 57,524 | |
Apr 16 2015 | NERV | Minerva Neuroscien ... | Luthringer Remy | President, CEO & CS ... | Option Exercise | A | 5.19 | 399,623 | 2,074,043 | 399,623 | |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 6.25 | 6,700 | 41,875 | 1,662,592 | 1.7 M to 1.7 M (-0.40 %) |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.75 | 1,200,000 | 6,900,000 | 1,669,292 | 2.9 M to 1.7 M (-41.82 %) |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | P | 5.77 | 202,634 | 1,169,603 | 202,634 | |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Buy | P | 4.81 | 202,634 | 974,670 | 5,488,272 | 5.3 M to 5.5 M (+3.83 %) |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Ollier Michele | Director | Option Exercise | P | 5.77 | 202,634 | 1,169,603 | 202,634 | |
Mar 20 2015 | NERV | Minerva Neuroscien ... | Ollier Michele | Director | Buy | P | 4.81 | 202,634 | 974,670 | 5,488,272 | 5.3 M to 5.5 M (+3.83 %) |
Mar 20 2015 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Option Exercise | P | 5.77 | 202,634 | 1,169,603 | 202,634 | |
Mar 20 2015 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | P | 4.81 | 202,634 | 974,670 | 5,488,272 | 5.3 M to 5.5 M (+3.83 %) |
Mar 17 2015 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | P | 5.77 | 607,903 | 3,508,816 | 607,903 | |
Mar 17 2015 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 4.81 | 607,903 | 2,924,013 | 4,500,159 | 3.9 M to 4.5 M (+15.62 %) |
Feb 04 2015 | NERV | Minerva Neuroscien ... | VAN HEEK G JAN | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Feb 04 2015 | NERV | Minerva Neuroscien ... | Beer Marc D | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Jan 26 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.02 | 23,111 | 116,017 | 2,869,292 | 2.9 M to 2.9 M (-0.80 %) |
Jan 26 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.14 | 63,304 | 325,383 | 2,892,403 | 3 M to 2.9 M (-2.14 %) |
Jan 26 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.11 | 395,697 | 2,022,012 | 2,955,707 | 3.4 M to 3 M (-11.81 %) |
Jan 08 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.66 | 70,659 | 399,930 | 3,351,404 | 3.4 M to 3.4 M (-2.06 %) |
Jan 08 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 5.85 | 64,278 | 376,026 | 3,422,063 | 3.5 M to 3.4 M (-1.84 %) |
Jan 08 2015 | NERV | Minerva Neuroscien ... | Care Capital III LLC | 10% Owner | Sell | S | 7.94 | 396,871 | 3,151,156 | 3,486,341 | 3.9 M to 3.5 M (-10.22 %) |
Sep 03 2014 | NERV | Minerva Neuroscien ... | Levine Mark S. | Vice President,Gene ... | Option Exercise | A | 7.10 | 93,541 | 664,141 | 93,541 | |
Jul 11 2014 | NERV | Minerva Neuroscien ... | Luthringer Remy | EVP and Head of R&D | Option Exercise | A | 6.00 | 207,869 | 1,247,214 | 649,842 | |
Jul 11 2014 | NERV | Minerva Neuroscien ... | Luthringer Remy | EVP and Head of R&D | Option Exercise | A | 6.00 | 441,973 | 2,651,838 | 441,973 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Race Geoff | EVP and CFO | Option Exercise | A | 6.00 | 249,442 | 1,496,652 | 346,585 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Race Geoff | EVP and CFO | Option Exercise | A | 6.00 | 97,143 | 582,858 | 97,143 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Race Geoff | EVP and CFO | Buy | P | 6.00 | 33,333 | 199,998 | 206,648 | 173.3 K to 206.6 K (+19.23 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | Chief Accounting Of ... | Option Exercise | A | 6.00 | 93,541 | 561,246 | 93,541 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Ahlholm Frederick W | Chief Accounting Of ... | Buy | P | 6.00 | 10,000 | 60,000 | 10,000 | 0 to 10 K |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Option Exercise | C | 6.00 | 61,922 | 371,532 | 0 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Option Exercise | C | 6.00 | 114,077 | 684,462 | 0 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | P | 6.00 | 333,333 | 1,999,998 | 5,285,638 | 5 M to 5.3 M (+6.73 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | P | 6.00 | 1,287,500 | 7,725,000 | 4,952,305 | 3.7 M to 5 M (+35.13 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | C | 6.00 | 61,922 | 371,532 | 3,664,805 | 3.6 M to 3.7 M (+1.72 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | De Rubertis Francesco | Director | Buy | C | 6.00 | 114,077 | 684,462 | 3,602,883 | 3.5 M to 3.6 M (+3.27 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | C | 6.00 | 61,922 | 371,532 | 0 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Option Exercise | C | 6.00 | 114,077 | 684,462 | 0 | |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Buy | P | 6.00 | 333,333 | 1,999,998 | 5,285,638 | 5 M to 5.3 M (+6.73 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Buy | P | 6.00 | 1,287,500 | 7,725,000 | 4,952,305 | 3.7 M to 5 M (+35.13 %) |
Jul 09 2014 | NERV | Minerva Neuroscien ... | Index Venture Associates III L ... | 10% Owner | Buy | C | 6.00 | 61,922 | 371,532 | 3,664,805 | 3.6 M to 3.7 M (+1.72 %) |